Anthony D'Adamio Bioventus Inc. (BVS) insider trading activity

Anthony D'Adamio is SVP & General Counsel of Bioventus Inc.. Currently has a direct ownership of 124,449 shares of BVS, which is worth approximately $1.2 Million. The most recent transaction as insider was on Mar 17, 2025, when has been sold 2,615 shares (Class A Common Stock) at a price of $9.75 per share, resulting in proceeds of $25,496. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 124K

7.82% 3M change

142.26% 12M change

Total Value Held $1.2 Million

Anthony D'Adamio Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 17 2025	SELL Open market or private sale	$25,496 $9.75 p/Share	2,615 Reduced 2.06%	124,449 Class A Common Stock
Mar 14 2025	BUY Exercise of conversion of derivative security	-	8,886 Added 6.54%	127,064 Class A Common Stock
Feb 18 2025	SELL Open market or private sale	$44,632 $10.19 p/Share	4,380 Reduced 3.57%	118,178 Class A Common Stock
Feb 15 2025	BUY Exercise of conversion of derivative security	-	12,980 Added 9.58%	122,558 Class A Common Stock
Dec 23 2024	SELL Open market or private sale	$61,579 $10.53 p/Share	5,848 Reduced 5.07%	109,578 Class A Common Stock
Dec 20 2024	BUY Exercise of conversion of derivative security	-	19,850 Added 14.67%	115,426 Class A Common Stock
Jun 21 2024	SELL Open market or private sale	$32,885 $5.57 p/Share	5,904 Reduced 5.82%	95,576 Class A Common Stock
Jun 20 2024	BUY Exercise of conversion of derivative security	-	19,850 Added 16.36%	101,480 Class A Common Stock
Jun 17 2024	SELL Open market or private sale	$66,038 $5.84 p/Share	11,308 Reduced 12.17%	81,630 Class A Common Stock
Jun 15 2024	BUY Exercise of conversion of derivative security	-	34,696 Added 27.18%	92,938 Class A Common Stock
Apr 11 2024	SELL Open market or private sale	$14,506 $4.75 p/Share	3,054 Reduced 4.98%	58,242 Class A Common Stock
Apr 10 2024	BUY Exercise of conversion of derivative security	-	9,925 Added 13.94%	61,296 Class A Common Stock
Mar 15 2024	SELL Open market or private sale	$17,062 $5.46 p/Share	3,125 Reduced 5.73%	51,371 Class A Common Stock
Mar 14 2024	BUY Exercise of conversion of derivative security	-	8,886 Added 14.02%	54,496 Class A Common Stock
Mar 15 2023	SELL Open market or private sale	$4,738 $1.39 p/Share	3,409 Reduced 6.95%	45,610 Class A Common Stock
Mar 14 2023	BUY Exercise of conversion of derivative security	-	8,887 Added 15.35%	49,019 Class A Common Stock
Apr 04 2022	SELL Open market or private sale	$179,219 $11.19 p/Share	16,016 Reduced 28.52%	40,132 Class A Common Stock
Apr 01 2022	BUY Exercise of conversion of derivative security	-	37,476 Added 40.03%	56,148 Class A Common Stock
Feb 14 2022	SELL Open market or private sale	$15,515 $11.99 p/Share	1,294 Reduced 6.48%	18,672 Class A Common Stock
Feb 11 2022	BUY Exercise of conversion of derivative security	-	4,400 Added 18.06%	19,966 Class A Common Stock
Feb 10 2022	BUY Payment of exercise price or tax liability	$84,995 $12.88 p/Share	6,599 Added 29.77%	15,566 Class A Common Stock
Feb 10 2022	BUY Exercise of conversion of derivative security	-	21,165 Added 48.85%	22,165 Class A Common Stock
Feb 11 2021	BUY Open market or private purchase	$13,000 $13.0 p/Share	1,000 Added 50.0%	1,000 Common Stock

Anthony D'Adamio

SVP & General Counsel

Durham, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BVS shares.

Notify only if

Value

Insider Trading

Get notified when an Bioventus Inc. insider buys or sells BVS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Bioventus Inc.

Track Activities on BVS

Account